Minimal Residual Disease Market Outlook: Innovations in MRD Testing and Cancer Diagnostics
The Minimal Residual Disease Market is gaining significant momentum as precision oncology continues to transform cancer diagnosis and treatment. Healthcare providers are increasingly adopting highly sensitive diagnostic technologies to monitor treatment response, identify disease recurrence at an early stage, and support personalized therapeutic decisions. As the global burden of cancer rises,...
